Dsrna targeting mapt and pharmaceutical use thereof
Patent Information
- Application Number
- HK62026126738
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-01-23
- Filing Date
- 2026-07-28
- Publication Date
- 2026-09-18
- Estimated Expiration
- 2044-07-31
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480043241.6 (22) Application Date 2024.08.01 (66) Domestic Priority Data 202310956218.3 2023.08.01 CN 202410092507.8 2024.01.23 CN (85) PCT International Application Entering National Phase Date 2025.12.26 (86) PCT International Application Application Data PCT / CN2024 / 109181 2024.08.01 (87) PCT International Application Publication Data WO2025 / 026390 ZH 2025.02.06 (71) Applicant Shanghai Tuojie Biomedical Technology Co., Ltd. Address 201203 Room 103, Building 14, No. 3728 Jinke Road, Shanghai Pudong New Area Free Trade Zone (72) Inventors: Wen Yuhao, Chen Di, Lin Xiaoyan, Li Yunfei (74) Patent Agency: Beijing Gecheng Intellectual Property Agency Co., Ltd. 11314 Patent Attorney: Cheng Wei (51) Int.Cl. C12N 15 / 113 (2006.01) (54) Invention Title: dsRNA targeting MAPT and its pharmaceutical use (57) Abstract: dsRNA targeting MAPT, dsRNA conjugates and their pharmaceutical use. Pharmaceutical compositions, cells or kits containing the dsRNA, and methods of using the dsRNA to treat and / or prevent subjects with related disorders. CN 121511304 A 2026.02.10 CN 1 21 51 13 04 A